Visits for Possible COVID-19 in a Pediatric Primary Care Practice Early in the Pandemic

Alison Riese1, Jessica M Kelly1, Tzu-Chun Chu2

  • 1Division of General Pediatrics, Department of Pediatrics, Alpert Medical School of Brown University/Hasbro Children's Hospital, Providence, RI.

Insights

In pediatric sick visits, nearly a third were persons under investigation for COVID-19. Most children with COVID-19 symptoms had common respiratory signs, and testing had low thresholds.

Area of Science:

  • Pediatric infectious diseases
  • Public health surveillance
  • Epidemiology of viral infections

Background:

  • Children with COVID-19 typically exhibit mild symptoms.
  • Understanding outpatient pediatric encounters for COVID-19 is crucial for public health management.
  • Characterizing symptoms and testing patterns in pediatric primary care settings provides valuable insights.

Purpose of the Study:

  • To characterize the symptoms and COVID-19 testing practices for pediatric sick visits in an outpatient academic setting.
  • To identify factors associated with positive COVID-19 tests in children.
  • To evaluate the proportion of sick visits attributed to potential COVID-19 cases.

Main Methods:

  • Retrospective chart review of sick visits at a pediatric academic primary care clinic (April-August 2020).
  • Inclusion criteria: "persons under investigation" (PUIs) for COVID-19, recording symptoms, known COVID-19 contacts, and testing status.
  • Descriptive statistics and inferential tests (Chi-square/Fisher's exact) were employed for data analysis.

Main Results:

  • 32% of sick visits involved PUIs for COVID-19; 20% of these were via telehealth.
  • The most frequent symptoms reported were fever, congestion/rhinorrhea, and cough.
  • COVID-19 testing was performed on 76% of PUIs; only known contacts and loss of taste/smell significantly predicted positive tests.

Conclusions:

  • A substantial proportion of pediatric sick visits were for potential COVID-19, with most patients undergoing testing.
  • Fever, congestion, and cough were common symptoms in children with and without COVID-19.
  • The study suggests a low threshold for COVID-19 testing in pediatric patients presenting with relevant symptoms.
Abstract

Related Concept Videos

Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.2K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.2K
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
47
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
41
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
57